Dambkowski Carl

CIK 00019834762 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001983476

Recent Transactions

50 trades

Other
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-01-23+116,483→ 116,483 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-01-07−14,025→ 139,540 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-07$80.06/sh−100→ 212,523 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-07$79.04/sh−826→ 212,623 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-07$77.90/sh−14,820→ 213,449 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-07$77.13/sh−2,954→ 228,269 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-07$22.86/sh+14,025→ 231,223 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-01-02+83,690→ 83,690 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-12-04$75.00/sh−10,900→ 271,108 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-05$55.58/sh−5,607→ 282,686 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-05$53.62/sh−2,300→ 290,493 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-05$22.86/sh+8,060→ 292,793 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-11-05−8,060→ 153,565 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-05$56.51/sh−678→ 282,008 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-05$54.83/sh−2,200→ 288,293 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-10-01$39.80/sh−5,110→ 284,733 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-10-01−2,385→ 161,625 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-10-01$22.86/sh+2,385→ 289,843 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-09-03$37.82/sh−2,535→ 233,738 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-09-03$38.55/sh−190→ 233,548 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-08-06$37.78/sh−2,725→ 236,273 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-07-02−7,365→ 164,010 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-07-02$22.86/sh+7,365→ 249,088 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-07-02$46.26/sh−746→ 238,998 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-07-02$44.77/sh−6,409→ 242,679 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-07-02$45.49/sh−2,935→ 239,744 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-06-04$36.96/sh−2,725→ 241,723 total
Award
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2025-06-02+17,500→ 17,500 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-05-07$35.75/sh−2,725→ 244,448 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-04-02$37.03/sh−500→ 248,062 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-04-02$37.59/sh−889→ 247,173 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-04-02$35.56/sh−2,471→ 248,562 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-03-05$30.48/sh−1,590→ 251,033 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-02-05−795→ 171,375 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-02-05$22.86/sh+795→ 256,143 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-02-05$40.69/sh−3,520→ 252,623 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-01-02$46.42/sh−1,499→ 257,934 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-01-02$47.92/sh−100→ 255,348 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-01-02$47.21/sh−2,486→ 255,448 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-01-02−1,360→ 172,170 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-01-02$22.86/sh+1,360→ 259,433 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-12-11$48.62/sh−4,085→ 258,528 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-12-11$22.86/sh+1,815→ 262,613 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-12-11$50.00/sh−455→ 258,073 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2024-12-11−1,815→ 173,530 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2024-12-09+124,962→ 124,962 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-12-04$46.07/sh−6,665→ 260,798 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-11-06$59.96/sh−1,339→ 267,463 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-11-06$58.91/sh−5,326→ 268,802 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-10-02$56.16/sh−5,740→ 275,053 total

Companies

Recent Filings

Address

C/O ORUKA THERAPEUTICS, INC. 855 OAK GROVE AVE., SUITE 100

MENLO PARK, CA, 94025

View on SEC.gov